tech
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.
TL;DR
- OpenAI researcher Miles Wang is leaving to launch a new startup focused on AI for drug discovery.
- Wang is reportedly in talks to raise about $200 million at a $2 billion valuation.
- Several other OpenAI researchers are expected to join Wang's new company.
- The startup may focus on AI models that find new uses for existing drugs or those that previously failed trials.
- Investor interest in AI for life sciences is highlighted by other recent funding rounds in the sector.